Utility of in vivo transcription profiling for identifying Pseudomonas aeruginosa genes needed for gastrointestinal colonization and dissemination

PLoS ONE

Volumn 5, Issue 12, 2010, Pages 1-14

  Koh, Andrew Y ^a,b   Mikkelsen, Per J ^c   Smith, Roger S ^d   Coggshall, Kathleen T ^e   Kamei, Akinobu ^f   Givskov, Michael ^c   Lory, Stephen ^g   Pier, Gerald B ^f  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL RNA; MESSENGER RNA; MONOCLONAL ANTIBODY; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM MUTANT; BIOFILM; EXOS GENE; EXOT GENE; EXOU GENE; FEMALE; GASTROINTESTINAL INFECTION; GENE DELETION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE INSERTION; GENE LIBRARY; GENETIC TRANSCRIPTION; IN VIVO STUDY; MOUSE; NEUTROPENIA; NONHUMAN; NUCLEOTIDE SEQUENCE; OVERALL SURVIVAL; POPB GENE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SURVIVAL RATE; TRANSPOSON; WILD TYPE; ANIMAL; C3H MOUSE; CHEMISTRY; GASTROINTESTINAL TRACT; GENETICS; METABOLISM; MICROBIOLOGY; MUTATION; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION;

ANIMALIA; BACTERIA (MICROORGANISMS); MURINAE; MUS; PSEUDOMONAS AERUGINOSA;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOFILMS; GASTROINTESTINAL TRACT; GENE EXPRESSION PROFILING; MICE; MICE, INBRED C3H; MUTATION; NEUTROPENIA; NUCLEIC ACID HYBRIDIZATION; POLYMERASE CHAIN REACTION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TRANSCRIPTION, GENETIC; VIRULENCE FACTORS;

EID: 78650756407     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015131     Document Type: Article

References (50)

1. Drenkard E (2003) Antimicrobial resistance of Pseudomonas aeruginosa biofilms. Microbes Infect 5: 1213-1219.
2. Hentzer M, Eberl L, Givskov M (2005) Transcriptome analysis of Pseudomonas aeruginosa biofilm development: anaerobic respiration and iron limitation. Biofilms 2: 37-61.
3. Platt MD, Schurr MJ, Sauer K, Vazquez G, Kukavica-Ibrulj I, et al. (2008) Proteomic, Microarray and Signature Tagged Mutagenesis Analysis of Anaerobic Pseudomonas aeruginosa at pH 6.5, Representing Chronic Cystic Fibrosis Airway Conditions. J Bacteriol.
4. Waite RD, Paccanaro A, Papakonstantinopoulou A, Hurst JM, Saqi M, et al. (2006) Clustering of Pseudomonas aeruginosa transcriptomes from planktonic cultures, developing and mature biofilms reveals distinct expression profiles. BMC Genomics 7: 162.
5. Whiteley M, Bangera MG, Bumgarner RE, Parsek MR, Teitzel GM, et al. (2001) Gene expression in Pseudomonas aeruginosa biofilms. Nature 413: 860-864.
6. Son MS, Matthews WJ Jr., Kang Y, Nguyen DT, Hoang TT (2007) In vivo evidence of Pseudomonas aeruginosa nutrient acquisition and pathogenesis in the lungs of cystic fibrosis patients. Infect Immun 75: 5313-5324.
7. Koh AY, Priebe GP, Pier GB (2005) Virulence of Pseudomonas aeruginosa in a murine model of gastrointestinal colonization and dissemination in neutropenia. Infect Immun 73: 2262-2272.
8. Bodey GP, Bolivar R, Fainstein V, Jadeja L (1983) Infections caused by Pseudomonas aeruginosa. Rev Infect Dis 5: 279-313.
9. Bertrand X, Blasco G, Belle E, Boillot A, Capellier G, et al. (2003) [Pseudomonas aeruginosa epidemiology in intensive care units: importance of cross-transmission]. Ann Fr Anesth Reanim 22: 505-509.
10. Bertrand X, Thouverez M, Talon D, Boillot A, Capellier G, et al. (2001) Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units. Intensive Care Med 27: 1263-1268.
11. Aliaga L, Mediavilla JD, Cobo F (2002) A clinical index predicting mortality with Pseudomonas aeruginosa bacteraemia. J Med Microbiol 51: 615-619.
12. Marshall JC, Christou NV, Meakins JL (1993) The gastrointestinal tract. The "undrained abscess" of multiple organ failure. Ann Surg 218: 111-119.
13. Liberati NT, Urbach JM, Miyata S, Lee DG, Drenkard E, et al. (2006) An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc Natl Acad Sci U S A 103: 2833-2838. Epub 2006 Feb 2813.
14. Reuter S, Sigge A, Wiedeck H, Trautmann M (2002) Analysis of transmission pathways of Pseudomonas aeruginosa between patients and tap water outlets. Crit Care Med 30: 2222-2228.
15. Cuttelod M, Senn L, Terletskiy V, Nahimana I, Petignat C, et al. Molecular epidemiology of Pseudomonas aeruginosa in intensive care units over a 10-year period (1998-2007). Clin Microbiol Infect.
16. (2000) Pseudomonas dermatitis/folliculitis associated with pools and hot tubs- Colorado and Maine, 1999-2000. MMWR Morb Mortal Wkly Rep 49: 1087-1091.
17. Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, et al. (2000) Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 406: 959-964.
18. Wolfgang MC, Lee VT, Gilmore ME, Lory S (2003) Coordinate regulation of bacterial virulence genes by a novel adenylate cyclase-dependent signaling pathway. Dev Cell 4: 253-263.
19. Caiazza NC, O'Toole GA (2004) SadB is required for the transition from reversible to irreversible attachment during biofilm formation by Pseudomonas aeruginosa PA14. J Bacteriol 186: 4476-4485.
20. O'Toole GA, Kolter R (1998) Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis. Mol Microbiol 28: 449-461.
21. Whitchurch CB, Erova TE, Emery JA, Sargent JL, Harris JM, et al. (2002) Phosphorylation of the Pseudomonas aeruginosa response regulator AlgR is essential for type IV fimbria-mediated twitching motility. J Bacteriol 184: 4544-4554.
22. O'Toole GA, Gibbs KA, Hager PW, Phibbs PV, Jr., Kolter R (2000) The global carbon metabolism regulator Crc is a component of a signal transduction pathway required for biofilm development by Pseudomonas aeruginosa. J Bacteriol 182: 425-431.
23. Potvin E, Lehoux DE, Kukavica-Ibrulj I, Richard KL, Sanschagrin F, et al. (2003) In vivo functional genomics of Pseudomonas aeruginosa for highthroughput screening of new virulence factors and antibacterial targets. Environ Microbiol 5: 1294-1308.
24. Dean CR, Goldberg JB (2002) Pseudomonas aeruginosa galU is required for a complete lipopolysaccharide core and repairs a secondary mutation in a PA103 (serogroup O11) wbpM mutant. FEMS Microbiol Lett 210: 277-283.
25. Sheridan WG, Lowndes RH, Young HL (1990) Intraoperative tissue oximetry in the human gastrointestinal tract. Am J Surg 159: 314-319.
26. Czuprynski CJ, Faith NG, Steinberg H (2002) Ability of the Listeria monocytogenes strain Scott A to cause systemic infection in mice infected by the intragastric route. Appl Environ Microbiol 68: 2893-2900.
27. Pizzo PA, Poplack DG (2002) Principles and practice of pediatric oncology. Philadelphia, Pa: Lippincott Williams & Wilkins.
28. Mecsas J, Bilis I, Falkow S (2001) Identification of attenuated Yersinia pseudotuberculosis strains and characterization of an orogastric infection in BALB/c mice on day 5 postinfection by signature-tagged mutagenesis. Infect Immun 69: 2779-2787.
29. Skurnik M, Venho R, Bengoechea JA, Moriyon I (1999) The lipopolysaccharide outer core of Yersinia enterocolitica serotype O:3 is required for virulence and plays a role in outer membrane integrity. Mol Microbiol 31: 1443-1462.
30. Moller AK, Leatham MP, Conway T, Nuijten PJ, de Haan LA, et al. (2003) An Escherichia coli MG1655 lipopolysaccharide deep-rough core mutant grows and survives in mouse cecal mucus but fails to colonize the mouse large intestine. Infect Immun 71: 2142-2152.
31. Allewelt M, Coleman FT, Grout M, Priebe GP, Pier GB (2000) Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread. Infect Immun 68: 3998-4004.
32. Hauser AR (2009) The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol 7: 654-665.
33. Hauser AR, Cobb E, Bodi M, Mariscal D, Valles J, et al. (2002) Type III protein secretion is associated with poor clinical outcomes in patients with ventilatorassociated pneumonia caused by Pseudomonas aeruginosa. Crit Care Med 30: 521-528.
34. Roy-Burman A, Savel RH, Racine S, Swanson BL, Revadigar NS, et al. (2001) Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections. J Infect Dis 183: 1767-1774.
35. Vance RE, Rietsch A, Mekalanos JJ (2005) Role of the type III secreted exoenzymes S, T, and Y in systemic spread of Pseudomonas aeruginosa PAO1 in vivo. Infect Immun 73: 1706-1713.
36. Pier GB, Meluleni G, Neuger E (1992) A murine model of chronic mucosal colonization by Pseudomonas aeruginosa. Infect Immun 60: 4768-4776.
37. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284: 1318-1322.
38. Baltimore RS, Christie CD, Smith GJ (1989) Immunohistopathologic localization of Pseudomonas aeruginosa in lungs from patients with cystic fibrosis. Implications for the pathogenesis of progressive lung deterioration. Am Rev Respir Dis 140: 1650-1661.
39. Heydorn A, Ersboll B, Kato J, Hentzer M, Parsek MR, et al. (2002) Statistical analysis of Pseudomonas aeruginosa biofilm development: impact of mutations in genes involved in twitching motility, cell-to-cell signaling, and stationaryphase sigma factor expression. Appl Environ Microbiol 68: 2008-2017.
40. Macfarlane S, Furrie E, Cummings JH, Macfarlane GT (2004) Chemotaxonomic analysis of bacterial populations colonizing the rectal mucosa in patients with ulcerative colitis. Clin Infect Dis 38: 1690-1699. Epub 2004 May 1625.
41. Macfarlane S, McBain AJ, Macfarlane GT (1997) Consequences of biofilm and sessile growth in the large intestine. Adv Dent Res 11: 59-68.
42. Wilson M (2005) Microbial Inhabitants of Humans, Their Ecology and Role in Health and Disease. Cambridge: Cambridge University Press.
43. Acheson DW, Luccioli S (2004) Microbial-gut interactions in health and disease. Mucosal immune responses. Best Pract Res Clin Gastroenterol 18: 387-404.
44. Cohen PS, Arruda JC, Williams TJ, Laux DC (1985) Adhesion of a human fecal Escherichia coli strain to mouse colonic mucus. Infect Immun 48: 139-145.
45. Atuma C, Strugala V, Allen A, Holm L (2001) The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am J Physiol Gastrointest Liver Physiol 280: G922-929.
46. Stoodley P, Sauer K, Davies DG, Costerton JW (2002) Biofilms as complex differentiated communities. Annu Rev Microbiol 56: 187-209. Epub 2002 Jan 2030.
47. Alexander RJ, Raicht RF (1998) Purification of total RNA from human stool samples. Dig Dis Sci 43: 2652-2658.
48. Fitzsimons NA, Akkermans AD, de Vos WM, Vaughan EE (2003) Bacterial gene expression detected in human faeces by reverse transcription-PCR. J Microbiol Methods 55: 133-140.
49. Bright BD, Arora SK, Phibbs PV, Prince A (1995) Involvement ofthe crc locus in the regulation of the expression of Pseudomonas aeruginosa virulence factors. Pediatr Pulm 12S: 244-245.
50. Rahme LG, Stevens EJ, Wolfort SF, Shao J, Tompkins RG, et al. (1995) Common virulence factors for bacterial pathogenicity in plants and animals. Science 268: 1899-1902.